Aisling Capital’s Aimmune Therapeutics AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$26M Sell
2019
Q2
$41.4M Hold
2019
Q1
$44.5M Hold
2018
Q4
$47.6M Hold
2018
Q3
$54.3M Sell
2018
Q2
$60.2M Hold
2018
Q1
$71.3M Hold
2017
Q4
$84.7M Sell
2017
Q3
$74.1M Hold
2017
Q2
$61.5M Hold
2017
Q1
$65M Hold
2016
Q4
$61.1M Hold
2016
Q3
$44.9M Hold
2016
Q2
$32.4M Hold
2016
Q1
$40.5M Hold
2015
Q4
$55.2M Buy
2015
Q3
$71.4M Buy